Inovio Pharmaceuticals Inc (INO) — Financial Flexibility Index
Inovio Pharmaceuticals Inc (INO) has a Financial Flexibility Index of -0.28x as of September 2025. Free cash flow of $-21.51 Million (operating CF $-21.57 Million minus capex $67.95K) represents 0% of total liabilities ($77.11 Million). Check Inovio Pharmaceuticals Inc (INO) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Inovio Pharmaceuticals Inc Financial Flexibility Index (1998–2024)
Historical Financial Flexibility Index trend for Inovio Pharmaceuticals Inc across 27 annual periods. For the full cash flow conversion analysis, see INO cash generation efficiency.
Annual Financial Flexibility Index for Inovio Pharmaceuticals Inc (1998–2024)
Year-by-year free cash flow to debt coverage for Inovio Pharmaceuticals Inc. Explore Inovio Pharmaceuticals Inc (INO) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.32x | $-103.59 Million | $-104.08 Million | $44.69 Million | ▼ -0.2% |
| 2023 | -2.31x | $-124.04 Million | $-124.37 Million | $53.60 Million | ▼ -35.6% |
| 2022 | -1.71x | $-215.25 Million | $-216.22 Million | $126.17 Million | ▲ +23.4% |
| 2021 | -2.23x | $-214.48 Million | $-215.71 Million | $96.27 Million | ▲ +0.7% |
| 2020 | -2.24x | $-176.46 Million | $-177.98 Million | $78.63 Million | ▼ -221.0% |
| 2019 | -0.70x | $-96.86 Million | $-97.85 Million | $138.55 Million | ▲ +56.9% |
| 2018 | -1.62x | $-71.47 Million | $-73.55 Million | $44.08 Million | ▼ -37.1% |
| 2017 | -1.18x | $-52.92 Million | $-63.21 Million | $44.75 Million | ▼ -1.5% |
| 2016 | -1.16x | $-58.62 Million | $-62.56 Million | $50.33 Million | ▼ -357.2% |
| 2015 | -0.25x | $-9.66 Million | $-12.44 Million | $37.91 Million | ▲ +81.9% |
| 2014 | -1.40x | $-28.44 Million | $-29.82 Million | $20.25 Million | ▼ -226.9% |
| 2013 | -0.43x | $-15.20 Million | $-15.38 Million | $35.38 Million | ▲ +80.0% |
| 2012 | -2.15x | $-22.07 Million | $-22.31 Million | $10.28 Million | ▼ -45.1% |
| 2011 | -1.48x | $-19.59 Million | $-19.76 Million | $13.24 Million | ▼ -14.0% |
| 2010 | -1.30x | $-11.63 Million | $-11.94 Million | $8.97 Million | ▼ -81.3% |
| 2009 | -0.72x | $-13.92 Million | $-14.08 Million | $19.44 Million | ▼ -35.0% |
| 2008 | -0.53x | $-10.54 Million | $-11.13 Million | $19.88 Million | ▲ +57.4% |
| 2007 | -1.24x | $-10.87 Million | $-11.51 Million | $8.74 Million | ▼ -172.6% |
| 2006 | -0.46x | $-5.68 Million | $-7.04 Million | $12.45 Million | ▲ +79.2% |
| 2005 | -2.19x | $-12.05 Million | $-12.34 Million | $5.51 Million | ▼ -76.5% |
| 2004 | -1.24x | $-6.70 Million | $-6.80 Million | $5.40 Million | ▲ +45.5% |
| 2003 | -2.28x | $-2.69 Million | $-2.75 Million | $1.18 Million | ▲ +15.3% |
| 2002 | -2.69x | $-4.55 Million | $-4.96 Million | $1.69 Million | ▲ +44.6% |
| 2001 | -4.85x | $-8.11 Million | $-8.37 Million | $1.67 Million | ▲ +8.9% |
| 2000 | -5.33x | $-8.50 Million | $-8.79 Million | $1.60 Million | ▼ -100.3% |
| 1999 | -2.66x | $-5.80 Million | $-6.30 Million | $2.18 Million | ▲ +31.2% |
| 1998 | -3.87x | $-5.80 Million | $-6.30 Million | $1.50 Million | — |